Home068270 • KRX
add
Celltrion Inc
Previous close
₩159,800.00
Day range
₩158,300.00 - ₩160,800.00
Year range
₩152,666.67 - ₩200,952.39
Market cap
35.52T KRW
Avg Volume
466.49K
P/E ratio
77.69
Dividend yield
0.45%
In the news
Financials
Income Statement
Revenue
Net income
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.06T | 178.01% |
Operating expense | 347.40B | 182.95% |
Net income | 236.65B | 22,354.46% |
Net profit margin | 22.25 | 7,846.43% |
Earnings per share | 1.15K | 13,270.00% |
EBITDA | 275.17B | 201.50% |
Effective tax rate | 14.02% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.14T | 50.90% |
Total assets | 21.06T | 5.50% |
Total liabilities | 3.48T | 22.75% |
Total equity | 17.58T | — |
Shares outstanding | 215.26M | — |
Price to book | 1.97 | — |
Return on assets | 2.37% | — |
Return on capital | 2.52% | — |
Cash Flow
Net change in cash
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 236.65B | 22,354.46% |
Cash from operations | 305.93B | 104.51% |
Cash from investing | -101.50B | -175.12% |
Cash from financing | -228.94B | -214.96% |
Net change in cash | 23.77B | -88.30% |
Free cash flow | 61.13B | 103.98% |
About
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Founded
2002
Website
Employees
1,074
